Dakota Wealth Management Raises Holdings in The Clorox Company (NYSE:CLX)

Dakota Wealth Management lifted its position in shares of The Clorox Company (NYSE:CLX) by 15.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 13,739 shares of the company’s stock after purchasing an additional 1,829 shares during the period. Dakota Wealth Management’s holdings in Clorox were worth $2,238,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. SG Americas Securities LLC increased its position in Clorox by 1,525.7% in the 1st quarter. SG Americas Securities LLC now owns 65,612 shares of the company’s stock valued at $10,046,000 after acquiring an additional 61,576 shares during the period. Mizuho Markets Americas LLC raised its position in Clorox by 93.7% in the first quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock worth $11,032,000 after acquiring an additional 34,864 shares in the last quarter. CANADA LIFE ASSURANCE Co raised its position in Clorox by 15.2% in the first quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company’s stock worth $21,705,000 after acquiring an additional 18,687 shares in the last quarter. Advisors Asset Management Inc. lifted its holdings in Clorox by 257.5% in the first quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company’s stock valued at $1,719,000 after acquiring an additional 8,087 shares during the period. Finally, Raymond James & Associates boosted its position in shares of Clorox by 32.8% during the 2nd quarter. Raymond James & Associates now owns 267,632 shares of the company’s stock worth $36,524,000 after purchasing an additional 66,149 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.51% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

CLX has been the subject of several recent analyst reports. JPMorgan Chase & Co. raised their price objective on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research note on Friday, October 11th. Evercore ISI reduced their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Citigroup upped their price target on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. DA Davidson reaffirmed a “neutral” rating and set a $153.00 price objective on shares of Clorox in a report on Friday, September 6th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Six analysts have rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the company. According to MarketBeat, Clorox has an average rating of “Hold” and an average price target of $150.14.

Clorox Stock Performance

Shares of NYSE CLX opened at $156.69 on Friday. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The company has a market cap of $19.46 billion, a PE ratio of 81.19, a price-to-earnings-growth ratio of 3.19 and a beta of 0.41. The company has a 50-day simple moving average of $160.74 and a 200-day simple moving average of $145.61. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.09.

Clorox (NYSE:CLX) last released its earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The firm had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. On average, equities analysts anticipate that The Clorox Company will post 6.64 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 3.11%. Clorox’s dividend payout ratio (DPR) is presently 252.85%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.